ALDH1A1 and ovarian carcinoma: Ayub et al. showed that ovarian cancer stem cells, defined by their high ALDH1 activity, preferentially survive and increase in number after NAC and that such enrichment of ALDH1 expression is associated with unfavorable survival outcomes in patients with advanced ovarian cancer [44].